Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M. Snyder, Kate Dixon, Zachary Davis, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007280-e007280
Open Access | Times Cited: 13

Showing 13 citing articles:

Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications
Qi Lei, Hongkui Deng, Shicheng Sun
Life Medicine (2025) Vol. 4, Iss. 1
Open Access
Gene-modified NK cells expressing CD64 and preloaded with HIV-specific BNAbs target autologous HIV-1–infected CD4+ T cells by ADCC
Costin Tomescu, Adiana Ochoa-Ortiz, Lily Lu, et al.
The Journal of Immunology (2025)
Closed Access
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4335-4357
Open Access
Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer
Yi-Ying Wu, Ming-Shan Chen, I‐Chun Chen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3236-3236
Open Access
Cryopreservation practices in clinical and preclinical iPSC‐based cell therapies: Current challenges and future directions
Michael Dobruskin, Geoffrey Toner, Ronald Kander
Biotechnology Progress (2025)
Open Access
A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy
Gustavo Rodrigues Rossi, Jane Sun, Cheng‐Yu Lin, et al.
Immunology and Cell Biology (2024)
Open Access | Times Cited: 3
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Jennifer D. Wu
BioDrugs (2024) Vol. 38, Iss. 4, pp. 499-509
Open Access | Times Cited: 1
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
Kate Dixon, Kristin M. Snyder, Melissa Khaw, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W. Matson, Rob H. Hullsiek, Kate Dixon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gene-modified NK Cells Expressing CD64 and Pre-loaded with HIV-specific BNAbs Target Autologous HIV-1 Infected CD4+T Cells by ADCC
Costin Tomescu, Adiana Ochoa Ortiz, Lily Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W. Matson, Rob H. Hullsiek, Kate Dixon, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008959-e008959
Open Access
Research Progress on Peripheral Blood Biomarkers Based on PD-1/PD-L1 Inhibitors for Advanced Non-Small Cell Lung Cancer
雅楠 苗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 126-133
Closed Access
Engineered Cellular Therapies for the Treatment of Thoracic Cancers
Spencer M Erickson, Benjamin M. Manning, Akhilesh Kumar, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 35-35
Open Access
Page 1

Scroll to top